Postpartum bilateral lung transplantation in COVID-19 associated respiratory failure
Open Access
- 16 May 2022
- journal article
- research article
- Published by BMJ in BMJ Case Reports
- Vol. 15 (5) , e249159
Abstract
In critically ill patients with COVID-19, established therapies in the setting of respiratory failure include invasive mechanical ventilation and extracorporeal membrane oxygenation (ECMO). This case report describes a pregnant woman in her 30s who was hospitalised at 35 weeks gestation with moderate COVID-19 disease. Her condition worsened following delivery, and she required intubation, maximum ventilatory support and ECMO. Because of the severe and irreversible nature of her lung disease, she ultimately underwent bilateral lung transplantation. This case showcases lung transplantation as an alternative life-saving option for patients with severe COVID-19 associated respiratory failure refractory to ECMO and mechanical ventilation. Further studies are needed to develop a multidisciplinary approach for patient selection for transplantation within the context of COVID-19 and to assess long-term outcomes.Keywords
This publication has 6 references indexed in Scilit:
- Early outcomes after lung transplantation for severe COVID-19: a series of the first consecutive cases from four countriesThe Lancet Respiratory Medicine, 2021
- COVID‐19‐related disease severity in pregnancyAmerican Journal of Reproductive Immunology, 2020
- Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS)Medical Science Monitor, 2020
- The tragedy of COVID‐19 in Brazil: 124 maternal deaths and countingInternational Journal of Gynecology & Obstetrics, 2020
- Survival in adult lung transplantation: where are we in 2020?Current Opinion in Organ Transplantation, 2020
- Acute respiratory failure in COVID-19: is it “typical” ARDS?Critical Care, 2020